Titre que je trouve très intéressant que j’ai découvert cette semaine. Ils sont cash flow positif depuis aout selon la nouvelle de cette semaine. De plus, ils ont beaucoup d’argent dans leur compte et aucune dette à long terme. Voir ce qui suit…
en date du 31 juillet…
Cash : 8 900 000 $
Compte payable : 1 400 000$
Market cap actuel : 16 800 000$
Les revenus augmentent rapidement de trimestre en trimestre et il semble, toujours selon le communiqué de cette semaine, que l’accèlération des revenus est au maximum présentement. Leur argent provient d’un financement en décembre 2016 par Aphria au prix de 1.40$ l’action. Le genre de titre que la patience peut faire rapporter gros. La hausse de cette semaine et les bons volumes qui ont suivi me donne confiance en ce titre pour le cours et le moyen terme.
Voici le communiqué de cette semaine…
Canabo Medical’s patient base reaches 25,000 in Q3
2017-10-03 11:24 ET - News Release
Mr. John Philpott reports
CANABO MEDICAL ACHIEVES POSITIVE CASH FLOW AND ENJOYS RECORD GROWTH
Canabo Medical Inc.'s management has determined that the company is cash flow positive for August and anticipates continued positive growth for the remainder of the fourth quarter of 2017.
The company’s year-over-year increases (for the nine months ended July 31, 2017, and 2016) demonstrate growth in the following areas:
82-per-cent increase in clinic revenue;
154-per-cent increase in research revenue;
Overall revenue doubled (100-per-cent increase);
Clinics have increased from 10 to 19;
Patient base has more than doubled from 10,000 to over 25,000 patients.
The trend is continuing into the fourth quarter with:
Canabo setting a record of more than 1,270 new patient appointments in August;
Canabo physicians seeing in excess of 3,000 new and recheck patients monthly and expecting total patient appointments for fiscal 2017 to exceed 50,000;
Canabo holding numerous continuing medical education seminars reaching in excess of 1,000 referring physicians across the country.
John Philpott, Canabo’s chief executive officer, commented: “We are delighted that the company is now cash flow positive and enjoying the fastest rate of growth since inception. We have been working diligently to build a national network of clinics and emphasize the importance of growth within our cannibinoid research partnerships.”
About Canabo Medical Inc.
Canabo wholly owns and operates Cannabinoid Medical Clinics, or CMClinics, Canada’s largest physician-led, referral-only clinics for medical cannabis. Established in 2014, Canabo now has 19 clinics across Canada, with additional locations planned to open in 2017.
Canabo operates referral-only medical clinics dedicated to evaluating the suitability of prescribing and monitoring cannabinoid treatments for patients suffering from chronic pain and disabling illnesses.
We seek Safe Harbor.